ATE297727T1 - Verwendung von anethol-dithiolethion zur vorbeugung und behandlung der sehnentoxizität - Google Patents

Verwendung von anethol-dithiolethion zur vorbeugung und behandlung der sehnentoxizität

Info

Publication number
ATE297727T1
ATE297727T1 AT01929703T AT01929703T ATE297727T1 AT E297727 T1 ATE297727 T1 AT E297727T1 AT 01929703 T AT01929703 T AT 01929703T AT 01929703 T AT01929703 T AT 01929703T AT E297727 T1 ATE297727 T1 AT E297727T1
Authority
AT
Austria
Prior art keywords
dithiolethone
anethol
prevent
toxicity
treat tendon
Prior art date
Application number
AT01929703T
Other languages
English (en)
Inventor
Marie-Odile Christen
Jean-Michel Warnet
Patrice Rat
Original Assignee
Solvay Pharma Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharma Sas filed Critical Solvay Pharma Sas
Application granted granted Critical
Publication of ATE297727T1 publication Critical patent/ATE297727T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Lubricants (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
AT01929703T 2000-04-25 2001-04-25 Verwendung von anethol-dithiolethion zur vorbeugung und behandlung der sehnentoxizität ATE297727T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0005247A FR2807944B1 (fr) 2000-04-25 2000-04-25 Utilisation de l'anethole-dithiolethione dans la prevention et le traitement de la tenotoxicite induite par un medicament
PCT/FR2001/001268 WO2001080856A2 (fr) 2000-04-25 2001-04-25 Utilisation de l'anethole-dithiolethione dans la prevention et le traitement de la tenoxicite induite par un medicament

Publications (1)

Publication Number Publication Date
ATE297727T1 true ATE297727T1 (de) 2005-07-15

Family

ID=8849561

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01929703T ATE297727T1 (de) 2000-04-25 2001-04-25 Verwendung von anethol-dithiolethion zur vorbeugung und behandlung der sehnentoxizität

Country Status (12)

Country Link
US (1) US20030187067A1 (de)
EP (1) EP1351680B8 (de)
JP (1) JP2003531172A (de)
AT (1) ATE297727T1 (de)
AU (1) AU2001256406A1 (de)
CA (1) CA2406998A1 (de)
DE (1) DE60111571T2 (de)
ES (1) ES2245361T3 (de)
FR (1) FR2807944B1 (de)
HU (1) HUP0301810A2 (de)
PT (1) PT1351680E (de)
WO (1) WO2001080856A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103113360B (zh) * 2013-02-19 2015-01-28 东南大学 一种阿托伐他汀衍生物、其药物组合物及制药应用
WO2018162846A1 (fr) * 2017-03-07 2018-09-13 Sauzieres, Jacques Prévention des effets adverses des especes reactives de l'oxygene d'origine mitochondriale à l'aide d'un inhibiteur specifique de la production de ros d'origine mitochondriale
CA3054992A1 (fr) * 2017-03-07 2018-09-13 Olivier Petitjean Prevention des risques associes a un allongement de l'intervalle qt d'origine medicamenteuse a l'aide d'un inhibiteur specifique de la production de ros d'origine mitochondriale

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL118778A (en) * 1995-07-03 1999-07-14 Sankyo Co Pharmaceutical compositions for the treatment of arteriosclerosis and xanthoma containing an hmg-coa reductase inhibitor

Also Published As

Publication number Publication date
ES2245361T3 (es) 2006-01-01
DE60111571D1 (de) 2005-07-21
EP1351680B1 (de) 2005-06-15
FR2807944B1 (fr) 2003-06-13
EP1351680B8 (de) 2005-08-17
US20030187067A1 (en) 2003-10-02
CA2406998A1 (fr) 2001-11-01
WO2001080856A3 (fr) 2003-04-24
WO2001080856A2 (fr) 2001-11-01
AU2001256406A1 (en) 2001-11-07
FR2807944A1 (fr) 2001-10-26
DE60111571T2 (de) 2006-05-11
HUP0301810A2 (hu) 2003-09-29
EP1351680A2 (de) 2003-10-15
PT1351680E (pt) 2005-10-31
JP2003531172A (ja) 2003-10-21

Similar Documents

Publication Publication Date Title
DE602004017736D1 (de) Verwendung von rapamycin und dessen derivaten zur behandlung von knochenverlust
DE60031396D1 (de) Zubereitung zur behandlung von einer neurologischen erkrankung
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE60124684D1 (de) Sulfonamido-substituierte verbrückte bicycloalkylderivative
DE60312736D1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
DE69825286D1 (de) Verwendung von cholinesterasehemmern zur behandlung von aufmerksamkeitsmangel-störungen
DE69825440D1 (de) VERWENDUNG VON TAUROLIDINE ZUR Herstellung eines Arzneimittels zur BEHANDLUNG VON LEUKÄMIEN
NO20025405D0 (no) Modulatorer for TNF-alfa-signalisering
DE69918972D1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
DE60030861D1 (de) Verwendung von escitalopram zur Behandlung von generalisierten Angstzuständen
ATE217191T1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
DE69931487D1 (de) Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation
ATE402694T1 (de) Verwendung von 1-phenyl-3-dimethylamino-propan- verbindungen zur therapie der harninkontinenz
ATE297727T1 (de) Verwendung von anethol-dithiolethion zur vorbeugung und behandlung der sehnentoxizität
ATE361071T1 (de) Verwendung von irbesartan zur vorbeugung oder behandlung pulmonaler hypertonie
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN
DE50212649D1 (de) Verwendung von desoxypeganin zur behandlung der klinischen depression
DE69918541D1 (de) Verwendung von nmda antagonisten zur behandlung des reizkolons
ATE354361T1 (de) Neue verwendung von prodigiosin zur behandlung von diabetes mellitus
DE69936779D1 (de) Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen
DE60124093D1 (de) S-methyl-dihydro-ziprasidon zur Behandlung von Augenerkrankungen.
DE50302552D1 (de) Verwendung von treosulfan und derivaten davon zur behandlung der multiplen sklerose
ATE275949T1 (de) Verwendung von diminazen-di-aceturat und/oder pentamidin zur behandlung von malaria
DE60326348D1 (de) Makrozyclen zur behandlung von krebserkrankungen
ATE432359T1 (de) Modulation der s6-kinaseaktivität zur behandlung von adipositas

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties